rs3862792

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_053056.3(CCND1):​c.669C>T​(p.Phe223Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0356 in 1,613,888 control chromosomes in the GnomAD database, including 1,820 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.060 ( 452 hom., cov: 33)
Exomes 𝑓: 0.033 ( 1368 hom. )

Consequence

CCND1
NM_053056.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.69

Publications

27 publications found
Variant links:
Genes affected
CCND1 (HGNC:1582): (cyclin D1) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of human cancers. [provided by RefSeq, Dec 2019]
CCND1 Gene-Disease associations (from GenCC):
  • von Hippel-Lindau disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 11-69648088-C-T is Benign according to our data. Variant chr11-69648088-C-T is described in ClinVar as Benign. ClinVar VariationId is 1250573.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.69 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCND1NM_053056.3 linkc.669C>T p.Phe223Phe synonymous_variant Exon 4 of 5 ENST00000227507.3 NP_444284.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCND1ENST00000227507.3 linkc.669C>T p.Phe223Phe synonymous_variant Exon 4 of 5 1 NM_053056.3 ENSP00000227507.2
CCND1ENST00000542367.1 linkn.132C>T non_coding_transcript_exon_variant Exon 1 of 2 1
CCND1ENST00000545484.1 linkn.375C>T non_coding_transcript_exon_variant Exon 2 of 2 5
CCND1ENST00000536559.1 linkc.*89C>T 3_prime_UTR_variant Exon 2 of 2 3 ENSP00000438482.1

Frequencies

GnomAD3 genomes
AF:
0.0596
AC:
9070
AN:
152184
Hom.:
445
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.135
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.0453
Gnomad ASJ
AF:
0.0262
Gnomad EAS
AF:
0.0158
Gnomad SAS
AF:
0.0994
Gnomad FIN
AF:
0.00348
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0280
Gnomad OTH
AF:
0.0722
GnomAD2 exomes
AF:
0.0393
AC:
9888
AN:
251296
AF XY:
0.0408
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.0242
Gnomad ASJ exome
AF:
0.0251
Gnomad EAS exome
AF:
0.0103
Gnomad FIN exome
AF:
0.00508
Gnomad NFE exome
AF:
0.0293
Gnomad OTH exome
AF:
0.0414
GnomAD4 exome
AF:
0.0331
AC:
48352
AN:
1461586
Hom.:
1368
Cov.:
31
AF XY:
0.0346
AC XY:
25167
AN XY:
727116
show subpopulations
African (AFR)
AF:
0.139
AC:
4665
AN:
33474
American (AMR)
AF:
0.0258
AC:
1155
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0256
AC:
670
AN:
26134
East Asian (EAS)
AF:
0.0146
AC:
579
AN:
39700
South Asian (SAS)
AF:
0.0911
AC:
7857
AN:
86254
European-Finnish (FIN)
AF:
0.00547
AC:
291
AN:
53184
Middle Eastern (MID)
AF:
0.0753
AC:
434
AN:
5766
European-Non Finnish (NFE)
AF:
0.0271
AC:
30178
AN:
1111968
Other (OTH)
AF:
0.0418
AC:
2523
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2463
4927
7390
9854
12317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1234
2468
3702
4936
6170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0598
AC:
9110
AN:
152302
Hom.:
452
Cov.:
33
AF XY:
0.0594
AC XY:
4423
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.136
AC:
5639
AN:
41536
American (AMR)
AF:
0.0453
AC:
693
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0262
AC:
91
AN:
3470
East Asian (EAS)
AF:
0.0158
AC:
82
AN:
5182
South Asian (SAS)
AF:
0.0993
AC:
479
AN:
4824
European-Finnish (FIN)
AF:
0.00348
AC:
37
AN:
10626
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0280
AC:
1904
AN:
68036
Other (OTH)
AF:
0.0757
AC:
160
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
408
816
1225
1633
2041
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0414
Hom.:
323
Bravo
AF:
0.0636
Asia WGS
AF:
0.0930
AC:
325
AN:
3478
EpiCase
AF:
0.0335
EpiControl
AF:
0.0341

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

CCND1-related disorder Benign:1
Jan 20, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
13
DANN
Benign
0.87
PhyloP100
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3862792; hg19: chr11-69462856; API